Technical Analysis with a Quantitative Edge

SIGN UP  |  LOGIN

HOW IT WORKS    TRADE SIGNALS    SCREENER    MY PORTFOLIO    HELP

ACELRX PHARMACEUTICALS INC (ACRX)
Equity - Health Care -

 

As of 2018-06-22

Add to My Portfolio
Close4.00Open4.05
Prev Close4.05Daily Chg-0.05 (-1.23%)
High4.10Volume508,388
Low3.9052-Week High/Low5.50 / 1.70
Dividend Yield0%Curr P/EN/A
Curr Year EPS Est-1.11Fwd P/EN/A
P/BN/AShort Ratio2.51
P/S5.39PEG Ratio0.00
Latest QuantForecast
As Of
Customize QuantForecast   View Commentary & Pattern   Save To My Forecasts     Share

 
 
 

SUPPORT
9EMA: 3.98 20SMA: 3.73 Lower Boll Band: 3.10
RESISTANCE
Upper Boll Band: 4.36
COMMENTARY
Strong uptrend across all timeframes . However, Momentum is deteriorating with Slow Stochastics turning lower and Fast Stochastics turning lower and MACD crossing negatively. Near-term technicals are overbought with RSI near historical high. Forecast points to higher price but with choppy action
TECHNICAL PATTERN

TYPEDESCRIPTION (?)CRITERIA (?)
Overbought Condition RSI near historical high at 67.64, occurred 9.36% of the time RSI = 67.64 +- 0.44
Long-Term Up Trend 200-Day Simple Moving Average is Trending Higher 200SMA Trend > 0
FORECAST STATISTICS
TIMEFRAME 2-DAY 5-DAY 10-DAY 20-DAY
Average +3.46% -0.31% -1.88% +6.80%
Best +15.07% +19.60% +16.64% +30.96%
Worst -8.26% -11.21% -17.11% -40.09%
% Positive 50% 40% 40% 70%
Outlook NEUTRAL NEUTRAL NEUTRAL BULLISH
HISTORICAL MATCHES (?)
MATCH DATE 2-DAY 5-DAY 10-DAY 20-DAY
2018-06-22 0% 0% 0% 0%
2018-04-19 -5.15% -5.15% 0.00% +23.71%
2016-08-12 -4.29% -9.38% -13.94% -10.99%
2014-07-03 -8.26% -8.35% -12.70% -40.09%
2013-12-20 +2.18% -0.09% +13.20% +7.50%
2013-06-14 -0.31% -7.48% -3.74% +28.56%
2013-06-07 +15.07% +10.82% +2.53% +30.96%
2013-05-23 +12.21% +19.60% +16.64% +19.60%
2013-01-17 +14.78% +5.54% +9.24% +11.50%
2012-11-23 +12.53% +2.65% -17.11% -6.02%
2012-02-07 -4.13% -11.21% -12.98% +3.24%
# Matches 10
TRADE SIGNALS ?
POSITIONENTRY DATEENTRY PRICETARGET PRICE (?)STOP PRICE (?)CURRENT PNL %
Premium Members Only

Upgrade Now & Subscribe to Daily Trade Signals

CLOSED TRADES
POSITIONENTRY DATEENTRY PRICEEXIT DATE EXIT PRICEREALIZED PNL %
Long 2017-09-08 3.30 2017-10-05 5.05 +53.03%
Short 2017-07-13 2.15 2017-07-14 2.40 -11.63%
Short 2016-10-07 3.71 2016-10-20 3.20 +13.75%
Short 2016-06-09 3.35 2016-06-29 2.70 +19.40%
Long 2016-01-08 3.44 2016-01-13 2.98 -13.37%
Long 2012-05-15 3.65 2012-05-23 3.45 -5.48%
LATEST BUZZ
@blabarca
Posted 2018-06-25T13:39:48Z
$ACRX
@williambrannen
Posted 2018-06-25T13:32:18Z
$ACRX so if all goes well with Europe approval. Can we expect a dancing partner with Dsuvia shortly after? To market in Europe?
@biotechnology
Posted 2018-06-25T13:21:51Z
$ACRX “There is no better form of abuse deterrence for an opioid than to ensure its administration under medically supervised conditions”
@EstimizeAlerts
Posted 2018-06-25T11:15:41Z
Estimize EPS expectations are 0.28% lower than that of Wall Street for $ACRX Q2 [Reporting 08/01 AMC] http://www.estimize.com/intro/acrx?chart=change-over-time&metric_name=eps&utm_content=ACRX&utm_medium=eps_difference&utm_source=stocktwits
@biotechnology
Posted 2018-06-25T09:36:51Z
$ACRX PDUFA: Nov 03, means adcom should be done by Oct 03. Which means the notice should be sent by Jul 03. If no news by mid Jul, no adcom!
@shumba
Posted 2018-06-24T21:49:20Z
$TNDM $ACRX $DEST $DVMT $FNKO $FOSL $GLUU $GORO $LMNX $LXRX $NDLS $NTRA $QSII $RUN $SAM $SEAS $SHAK $SVVC $VRA some current swing trades.
@perrysmith1
Posted 2018-06-24T20:34:19Z
@70sTwit @BullishJulian I just put $ACRX on my radar yesterday for my future investment! Anything you care to contribute? Thanks and gl
@70sTwit
Posted 2018-06-24T20:05:39Z
@BullishJulian $ACRX
@sky2pqt
Posted 2018-06-24T19:00:51Z
$ACRX I would not be surprised if they cancel adcom....drug is used under supervision....main concerns may be rems....
@ChartMill
Posted 2018-06-24T18:53:05Z
Looking at the yearly performance, $ACRX did better than 96% of all other stocks. https://www.chartmill.com/analyze.php?utm_source=stocktwits&utm_medium=TA&utm_content=TA&utm_campaign=social_tracking#/ACRX?key=f92f7b73-900a-464a-b192-03502d4323ad
@OlaAmigos1111
Posted 2018-06-24T15:42:18Z
$ACRX common November, get this baby cooking already. Any good news, like EU approval, will definitely propel in between...
@ChartMill
Posted 2018-06-23T17:56:04Z
$ACRX has an excellent technical rating and also presents a decent setup pattern. https://www.chartmill.com/analyze.php?utm_source=stocktwits&utm_medium=TA&utm_content=SETUP&utm_campaign=social_tracking#/ACRX?key=f92f7b73-900a-464a-b192-03502d4323ad
@CanDoRGR
Posted 2018-06-23T03:49:31Z
$ACRX solid week tweeters, 5% off a 4.22 High. Better to buy.
@CanDoRGR
Posted 2018-06-22T19:27:48Z
$ACRX would like to see this added to Russell Micro Cap Index; Russell annual re balance today
@raylin
Posted 2018-06-22T18:15:54Z
$ACRX Mgnt was diligent in addressing the CRL & refile.
@raylin
Posted 2018-06-22T18:11:24Z
$ACRX Mgmt incentives to obtain FDA app of Dsuvia.
@ChartMill
Posted 2018-06-22T16:54:05Z
$ACRX is one of the better performing stocks in the Drugs industry. https://www.chartmill.com/analyze.php?utm_source=stocktwits&utm_medium=TA&utm_content=TA&utm_campaign=social_tracking#/ACRX?key=f92f7b73-900a-464a-b192-03502d4323ad
@G_stang
Posted 2018-06-22T16:24:17Z
$ACRX man im almost tmepted to leave the whole position on for July, if it fails, November should hedge my loss
@amann6651
Posted 2018-06-22T16:21:58Z
$ACRX getting on position now Great Great entry LOVE IT
@blabarca
Posted 2018-06-22T16:11:15Z
$ACRX
ACRX LATEST NEWS
Shire (SHPG) HAE Drug Gets FDA Nod for Pediatric Population
Posted Fri, 22 Jun 2018 16:11:44 Z
Shire plc 160 SHPG announced that the FDA has approved the label expansion of its hereditary angioedema HAE drug Cinryze to use in children aged six years and above Cinryze has been approved in the United States since October 2008 for routine prophylaxis against attacks in adolescents... >>> Read More
Small Drugmakers Edging Out the Bigshots: 7 Stocks to Buy
Posted Tue, 19 Jun 2018 14:10:12 Z
While many investors eye large companies for safe investing small companies are in fact a great place to find big investment returns At present this holds true for the specialty pharma sector where the smaller drugmakers are performing better than their larger counterparts Most of these... >>> Read More
Top Ranked Momentum Stocks to Buy for June 15th
Posted Fri, 15 Jun 2018 18:07:39 Z
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today June 15th Asbury Automotive Group Inc ABG This automotive retailer has a Zacks Rank 2 Buy and witnessed the Zacks Consensus Estimate for its current year earnings advancing 3 9... >>> Read More
Health Care Sector Update for 05/24/2018: ATHN,CELG,ACRX,KPTI
Posted Thu, 24 May 2018 20:24:16 Z
Top Health Care StocksTop Health Care Stocks JNJ 1 04 JNJ 1 04 PFE 0 29 PFE 0 29 ABT 1 06 ABT 1 06 MRK 0 12 MRK 0 12 AMGN 1 00 AMGN 1 00 Health care stocks still were moderately lower including a nearly 0 3 decline for the NYSE Health Care Index in late trade Also today shares... >>> Read More
Health Care Sector Update for 05/24/2018: CELG,ACRX,KPTI
Posted Thu, 24 May 2018 18:24:12 Z
Top Health Care StocksTop Health Care Stocks JNJ 1 25 JNJ 1 25 PFE 0 33 PFE 0 33 ABT 1 23 ABT 1 23 MRK 0 25 MRK 0 25 AMGN 0 95 AMGN 0 95 Health care stocks were moderately lower including a nearly 0 4 decline for the NYSE Health Care Index in recent trade Also shares of... >>> Read More

WINGCHARTS.COM    HOW IT WORKS    TRADE SIGNALS    SCREENER    MY PORTFOLIO    HELP

 



Follow Us on StockTwits
Partners / Affiliates

Copyright © 2017 WingCapital Co., Ltd. All Rights Reserved.

Disclaimer: Past results are not necessarily indicative of future performance. This website is for educational purposes only. No content published in this website, services and products constitutes a recommendation that any particular investment, security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Practical use of the content, forecasts, charts and services provided in this website are at your own risk and WingCapital Co., Ltd., WingCharts.com, its partners, representatives and employees assume no responsibility or liability for any use of the website. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Trade signals shown are hypothetical and do not represent actual trades. Actual results may differ. Views, forecasts and commentaries expressed in this website are WingCapital Co., Ltd.'s own opinions, and are not guarantees of future performance, and are subject to change over time.

WingCharts.com and WingCapital Co., Ltd. are not registered investment advisor or a broker dealer and do not give individualized market advice. The information on this website is for illustration purposes only and should not be considered as a solicitation of an offer on the purchase or sale of any securities. Trading in the securities markets involves substantial risk and should not be undertaken without due diligence and serious independent study. WingCapital Co., Ltd. recommends consulting a licensed professional broker regarding your personal investments. Without limitation, WingCapital Co., Ltd. shall not be responsible or liable for any loss or damages related to, either directly or indirectly, (1) any decline in market value or loss of any investment; (2) a subscribers inability to use or any delay in accessing the WingCharts.com website or any other source of material provided by WingCharts.com and WingCapital Co., Ltd.; (3) any absence or error of material on WingCharts.com website or presentation; (4) WingCapital Co., Ltd. failure to deliver or delay in delivering any material or (5) any kind of error in transmission of material.

ALL INFORMATION AND MATERIALS ARE PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, WITHOUT LIMITATION ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE.